Durembic Pharmaceutical Private Limited
About Durembic Pharmaceutical Private Limited
Data last updated:
Durembic Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24304PN2016PTC167380. Its GSTIN is 27AAFCD9218B1ZU (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pravin Sheshrao Mohod and Neelam Namdeorao Khandare.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at F2/903 Ganga Carnation Koregaon Park Annex Mundhwa, Pune, Maharashtra, India – 411036.
As per the financials filed for FY 2023, the company reported a revenue of ₹37.41 Lakh, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹31,389 (net margin 0.8%) and EBITDA of ₹47,018 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressF2/903 Ganga Carnation Koregaon Park Annex Mundhwa, Pune, Maharashtra, India – 411036
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Durembic Pharmaceutical Private Limited
The main business activity of Durembic Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Durembic Pharmaceutical Private Limited FY 2023 filings available
Durembic Pharmaceutical Private Limited reported revenue of ₹37.41 Lakh (up 20% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Durembic Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 20% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Durembic Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹47,018 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31,389 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Durembic Pharmaceutical Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Durembic Pharmaceutical are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Durembic Pharmaceutical Private Limited
Durembic Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sarvoshadhi Biotech Private Limited | ₹37.48 Lakh (FY 2025) | •••• | •••• | 525.0% | •••• | Kolhapur, Maharashtra, India |
| Hicure Life India Private Limited | ₹37.46 Lakh (FY 2025) | •••• | •••• | 362.0% | •••• | Coimbatore, Tamil Nadu, India |
| Fragante Diffusions Private Limited | ₹37.46 Lakh (FY 2024) | •••• | •••• | 70.0% | •••• | Kunnathunad, Kerala, India |
| We Care Pest Control Private Limited | ₹37.46 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | Chennai, Tamil Nadu, India |
| Soapsquare Healthcare Private Limited | ₹37.42 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Delhi, India |
| Durembic Pharmaceutical Private Limited this company | ₹37.41 Lakh (FY 2023) | •••• | •••• | 20.0% | •••• | Pune, Maharashtra, India |
| SV Biotech Private Limited | ₹37.4 Lakh (FY 2025) | •••• | •••• | -21.0% | •••• | Pune, Maharashtra, India |
| Zoneleaf Manufacturing and Trading Private Limited | ₹37.37 Lakh (FY 2021) | •••• | •••• | 177.0% | •••• | Malappuram, Kerala, India |
| Sanicor Life Science Private Limited | ₹37.35 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Kanpur, Uttar Pradesh, India |
| Surya Nutraceuticals Private Limited | ₹37.33 Lakh (FY 2025) | •••• | •••• | 15.0% | •••• | Varanasi, Uttar Pradesh, India |
| Amrut Drug Research Lab Pvt Ltd | ₹37.28 Lakh (FY 2025) | •••• | •••• | 554.0% | •••• | Palghar, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Durembic Pharmaceutical by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Durembic Pharmaceutical Private Limited
Durembic Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pravin Sheshrao Mohod | Director | 29 Jan 2020 | 6 Years 8 Months | Current |
| Neelam Namdeorao Khandare | Director | 05 Dec 2016 | 9 Years 10 Months | Current |
Ownership and Shareholding of Durembic Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Durembic Pharmaceutical Private Limited
Durembic Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Durembic Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Durembic Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Durembic Pharmaceutical Private Limited
Durembic Pharmaceutical Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Rahul Narhar Deshpande ceased to be Director on 14 Jan 2022.
Credit Ratings, Litigation & Regulatory Alerts for Durembic Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Durembic Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Durembic Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Durembic Pharmaceutical Private Limited
Durembic Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCD9218B1ZU | Maharashtra | Active | 07 Sep 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Durembic Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Durembic Pharmaceutical Private Limited
Durembic Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 December 2016 (10+ years old) and is registered under CIN U24304PN2016PTC167380.
Durembic Pharmaceutical reported revenue of ₹37.41 Lakh for FY 2023 (up 20% YoY).
Durembic Pharmaceutical has 2 current directors:
- Pravin Sheshrao Mohod - Director
- Neelam Namdeorao Khandare - Director
Durembic Pharmaceutical reported a net profit of ₹31,389 (net margin 0.8%) and EBITDA of ₹47,018 (EBITDA margin 1.3%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Durembic Pharmaceutical is 11% over three years and 17% over five years. In the latest year (FY 2023) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Durembic Pharmaceutical is 27AAFCD9218B1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Durembic Pharmaceutical is U24304PN2016PTC167380. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Durembic Pharmaceutical was incorporated on 05 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Durembic Pharmaceutical by revenue are Sarvoshadhi Biotech Private Limited, Hicure Life India Private Limited, Fragante Diffusions Private Limited, We Care Pest Control Private Limited, Soapsquare Healthcare Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Narhar Deshpande ceased to be Director on 14 Jan 2022. Pravin Sheshrao Mohod ceased to be Additional Director on 31 Dec 2020. Pravin Sheshrao Mohod was appointed as Director on 29 Jan 2020. Durembic Pharmaceutical has 5 board changes on record in total.
The registered office of Durembic Pharmaceutical is at F2903 Ganga Carnation Koregaon Park Annex Mundhwa, Pune, Maharashtra, India – 411036.